Compare BSX & AJG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BSX | AJG |
|---|---|---|
| Founded | 1979 | 1927 |
| Country | United States | United States |
| Employees | N/A | 706000 |
| Industry | Medical/Dental Instruments | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.0B | 55.0B |
| IPO Year | 2010 | 1995 |
| Metric | BSX | AJG |
|---|---|---|
| Price | $45.71 | $268.89 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 31 | 23 |
| Target Price | $59.24 | ★ $283.33 |
| AVG Volume (30 Days) | ★ 13.5M | 1.2M |
| Earning Date | 10-28-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 1.03% |
| EPS Growth | ★ 55.20 | N/A |
| EPS | 1.51 | ★ 4.41 |
| Revenue | ★ $9,076,000,000.00 | $6,159,600,000.00 |
| Revenue This Year | $5.41 | $27.69 |
| Revenue Next Year | $4.85 | $8.70 |
| P/E Ratio | ★ $30.40 | $61.19 |
| Revenue Growth | ★ 12.49 | N/A |
| 52 Week Low | $41.39 | $190.75 |
| 52 Week High | $105.65 | $281.66 |
| Indicator | BSX | AJG |
|---|---|---|
| Relative Strength Index (RSI) | 56.88 | 71.24 |
| Support Level | $42.31 | $239.44 |
| Resistance Level | $46.06 | $271.35 |
| Average True Range (ATR) | 1.16 | 6.02 |
| MACD | 0.44 | 4.61 |
| Stochastic Oscillator | 82.28 | 91.51 |
Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
Founded in 1927 as a one-person agency, Gallagher's primary business is insurance brokerage, with a focus on serving middle-market companies. The company's risk management segment provides third-party claims adjustment to companies that choose to self-insure. Gallagher has about 72,000 employees and generates about a third of its revenue internationally, primarily in Australia, Canada, New Zealand, and the UK.